FMP
BriaCell Therapeutics Corp.
BCTX
NASDAQ
BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, a personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada.
2.29 USD
0.085 (3.72%)
About
ceo
Dr. William V. Williams M.D.
sector
Healthcare
industry
Biotechnology
website
https://www.briacell.com
exchange
NASDAQ
Description
BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, a personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada.
CIK
0001610820
ISIN
CA1079301091
CUSIP
10778Y302
Address
Bellevue Centre
Phone
604 921 1810
Country
CA
Employee
16
IPO Date
Mar 14, 2012
Summary
CIK
0001610820
Exchange
NASDAQ
Industry
Biotechnology
Sector
Healthcare
CUSIP
10778Y302
ISIN
CA1079301091
Country
CA
Price
2.29
Beta
1.75
Volume Avg.
85.48k
Market Cap
36.52M
Shares
-
52-Week
2.01-7.59
DCF
0.99
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-2.89
P/B
-
Website
https://www.briacell.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest BCTX News
It looks like there's no news available.
